IPCS INCHEM Home

International Agency for Research on Cancer (IARC) - Summaries & Evaluations

17a-HYDROXYPROGESTERONE CAPROATE

VOL.: 21 (1979) (p. 399)

5. Summary of Data Reported and Evaluation

5.1 Experimental data

17a-Hydroxyprogesterone caproate was tested in rabbits by repeated intramuscular injection. The data were insufficient to evaluate the carcinogenicity of this compound.

5.2 Human data

No case reports or epidemiological studies on 17a-hydroxyprogesterone caproate were available to the Working Group.

5.3 Evaluation

The available experimental and human data are inadequate to evaluate the carcinogenicity of 17a-hydroxyprogesterone caproate.

For definition of the italicized terms, see Preamble Evaluation.

Subsequent evaluation: Suppl. 7 (1987) (Progestins)


Last updated: 6 April 1998






















    See Also:
       Toxicological Abbreviations